Literature DB >> 11790502

Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.

F Ingels1, S Deferme, E Destexhe, M Oth, G Van den Mooter, P Augustijns.   

Abstract

The Caco-2 model is widely used as a predictive tool for the oral absorption of drug candidates. Presently, transport experiments in the Caco-2 system are usually performed in 'HBSS-like' buffers. In this paper, we investigate the possibility of using simulated intestinal buffers as donor solvent during Caco-2 experiments. Toxicity assessment of these buffers on the monolayer showed that FASSIF was compatible with the Caco-2 model for at least 2 h. On the other hand, FESSIF was toxic to the monolayer. The functionality of the Caco-2 cells was assessed by determination of the transport of model compounds and the metabolic activity of hydrolases in presence of these buffers. Similar P(app) values for the (passive) theophyllin transport as well as for the (active) phenylalanine transport were obtained in TM and FASSIF. It was demonstrated that NaTC (present in FASSIF) had a P-gp inhibitory activity, as inclusion of NaTC in the apical compartment resulted in an increased absorptive and decreased secretory transport of CsA. The activity of the aminopeptidase enzyme was similar in both models. These results suggest that FASSIF can be used as an apical medium in the Caco-2 system. Since bile salts are also present in physiological conditions, the use of FASSIF may increase the relevance for the prediction of oral absorption using Caco-2 experiments.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790502     DOI: 10.1016/s0378-5173(01)00897-3

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  19 in total

Review 1.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

2.  Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines.

Authors:  Daniel A Carr; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2010-02       Impact factor: 4.396

Review 3.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

Review 4.  In vitro and in vivo models for the study of oral delivery of nanoparticles.

Authors:  Jennifer M Gamboa; Kam W Leong
Journal:  Adv Drug Deliv Rev       Date:  2013-02-13       Impact factor: 15.470

5.  Functional implications of modifying RyR-activating peptides for membrane permeability.

Authors:  Angela F Dulhunty; Louise Cengia; Jacqui Young; Suzy M Pace; Peta J Harvey; Graham D Lamb; Yiu-Ngok Chan; Norbert Wimmer; Istvan Toth; Marco G Casarotto
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

6.  Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel.

Authors:  Sungwon Kim; Ji Young Kim; Kang Moo Huh; Ghanashyam Acharya; Kinam Park
Journal:  J Control Release       Date:  2008-07-10       Impact factor: 9.776

7.  Optimisation of the caco-2 permeability assay using experimental design methodology.

Authors:  Mark Lakeram; David J Lockley; Ruth Pendlington; Ben Forbes
Journal:  Pharm Res       Date:  2008-02-22       Impact factor: 4.200

8.  Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.

Authors:  Matthew D Troutman; Dhiren R Thakker
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

9.  Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.

Authors:  Matthew D Troutman; Dhiren R Thakker
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

10.  Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.

Authors:  Yu-Yuan Chiu; Kazutaka Higaki; Brien L Neudeck; Jeffrey L Barnett; Lynda S Welage; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.